Indolo[2,3-a]carbazoles: diversity, biological properties, application in antitumor therapy

[Figure not available: see fulltext.] This review presents the history of the discovery of indolo[2,3-a]carbazoles, lists the currently known natural compounds of this subclass, and gives the sources for their isolation. The main approaches used to obtain synthetic indolo[2,3-a]carbazoles are described, and examples of compounds from this group that are most promising because of their high antitumor activity are given. The spectrum of biological properties of natural and synthetic compounds of this subclass is highlighted. The molecular mechanisms of their antitumor action as the most significant in the context of clinical use are separately considered. Particular attention is paid to indolo[2,3-a]- carbazoles that have reached clinical trials or are already in use for the treatment of malignant neoplasms. © 2020, Springer Science+Business Media, LLC, part of Springer Nature.

Авторы
Zenkov R.G.1 , Ektova L.V.1 , Vlasova O.А.1 , Belitskiy G.А.1 , Yakubovskaya M.G.1 , Kirsanov K.I. 1, 2
Издательство
Латвийский институт органического синтеза Латвийской академии наук / Springer New York Consultants Bureau
Номер выпуска
6
Язык
Английский
Страницы
644-658
Статус
Опубликовано
Том
56
Год
2020
Организации
  • 1 N. N. Blokhin Russian Cancer Research Center, 24 Kashirskoe shosse, Moscow, 115478, Russian Federation
  • 2 RUDN University, 6 Miklukho-Maklaya St., Moscow, 117198, Russian Federation
Ключевые слова
antitumor activity; indolocarbazoles; indolo[2,3-a]carbazoles; rebeccamycin; staurosporine
Дата создания
02.11.2020
Дата изменения
02.11.2020
Постоянная ссылка
https://repository.rudn.ru/ru/records/article/record/64669/
Поделиться

Другие записи